| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biochemistry (S.K.), Vanderbilt University Medical School, Nashville, Tennessee 37212; Cardiovascular Research Department (D.G.L.), Genentech, Inc., South San Francisco, California 94080; and Department of Pharmacology (G.J.T.), University of Minnesota-Duluth, School of Medicine, Duluth, Minnesota 55812
Address all correspondence and requests for reprints to: George J. Trachte, Department of Pharmacology, University of Minnesota-Duluth, School of Medicine, 10 University Drive, Duluth, Minnesota 55812. E-mail: gtracht1{at}d.umn.edu
Natriuretic peptides suppress adrenergic neurotransmission by a mechanism apparently involving the natriuretic peptide receptor-C (NPR-C) rather than particulate guanylyl cyclase receptors. The bulk of evidence implicating the NPR-C in neuromodulatory effects relies on the pharmacological specificity of peptides believed to be specific for the NPR-C. This study tests for NPR-C effects on neurotransmitter release by examining fragments of the receptor for biological activity in pheochromocytoma (PC12) cells permeabilized with digitonin. A pentadecapeptide segment of the cytoplasmic portion of the NPR-C mimicked the effect of natriuretic peptides to suppress dopamine efflux evoked by calcium approximately 40%. Furthermore, an antibody generated against the pentadecapeptide fragment abolished the neuromodulatory effect of C-type natriuretic peptide in permeabilized cells. In contrast, the carboxy terminal nonadecapeptide portion of the NPR-C failed to attenuate dopamine efflux. These data are consistent with the proposed role of the NPR-C in transducing the biological activity of natriuretic peptides in adrenergic tissue. The most novel aspect of these observations involves the potency of the small cytosolic region of the NPR-C with the region closest to the membrane accounting for neuromodulatory effects.
This article has been cited by other articles:
![]() |
S. Hashim, Y. Li, and M. B. Anand-Srivastava Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gi{alpha} protein/MAP kinase/PI3-kinase/AKT pathways Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3144 - H3153. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou and K. S. Murthy Identification of the G protein-activating sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C) Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1255 - C1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Trachte Natriuretic Peptides Suppress Protein Kinase C Activity to Reduce Evoked Dopamine Efflux from Pheochromocytoma (PC12) Cells Endocrinology, January 1, 2003; 144(1): 94 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Trachte Depletion of Natriuretic Peptide C Receptors Eliminates Inhibitory Effects of C-Type Natriuretic Peptide on Evoked Neurotransmitter Efflux J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 210 - 215. [Abstract] [Full Text] |
||||
![]() |
M. Pagano and M. B. Anand-Srivastava Cytoplasmic Domain of Natriuretic Peptide Receptor C Constitutes Gi Activator Sequences That Inhibit Adenylyl Cyclase Activity J. Biol. Chem., June 15, 2001; 276(25): 22064 - 22070. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |